Skip to content
10-Q

Quarterly Report

FURIEX PHARMACEUTICALS, INC.

0001437749-14-008599

← back to feed
Filed
May 9, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · Apr 30, 2014 10.81M sh
Shares Diluted Q1 2014 · Mar 31, 2014 10.44M sh
Shares Diluted Q1 2014 · Mar 31, 2013 10.87M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$9.17M
Operating Cash Flow Q1 2014 · Mar 31, 2013 $9.54M
Long Term Debt Q1 2014 · Mar 31, 2014 $27.72M
Long Term Debt Q1 2014 · Dec 31, 2013 $31.92M
Short Term Debt Q1 2014 · Mar 31, 2014 $14.28M
Short Term Debt Q1 2014 · Dec 31, 2013 $10.08M
Cash And Equivalents Q1 2014 · Mar 31, 2014 $22.9M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $29.15M
Cash And Equivalents Q1 2014 · Mar 31, 2013 $36.42M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $25.72M
Stockholders Equity Q1 2014 · Mar 31, 2014 $10.7M
Stockholders Equity Q1 2014 · Dec 31, 2013 $18.44M
Current Liabilities Q1 2014 · Mar 31, 2014 $26.97M
Current Liabilities Q1 2014 · Dec 31, 2013 $22.95M
Total Liabilities Q1 2014 · Mar 31, 2014 $69.42M
Total Liabilities Q1 2014 · Dec 31, 2013 $70M
Current Assets Q1 2014 · Mar 31, 2014 $29.58M
Current Assets Q1 2014 · Dec 31, 2013 $37.75M
Total Assets Q1 2014 · Mar 31, 2014 $80.12M
Total Assets Q1 2014 · Dec 31, 2013 $88.44M
Eps Diluted Q1 2014 · Mar 31, 2014 −$1.25
Eps Diluted Q1 2014 · Mar 31, 2013 $0.82
Eps Basic Q1 2014 · Mar 31, 2014 −$1.25
Eps Basic Q1 2014 · Mar 31, 2013 $0.89
Sga Expense Q1 2014 · Mar 31, 2014 $3.55M
Sga Expense Q1 2014 · Mar 31, 2013 $3.87M
Rd Expense Q1 2014 · Mar 31, 2014 $14.28M
Rd Expense Q1 2014 · Mar 31, 2013 $25.36M
Net Income Q1 2014 · Mar 31, 2014 −$13.05M
Net Income Q1 2014 · Mar 31, 2013 $8.97M
Operating Income Q1 2014 · Mar 31, 2014 −$11.42M
Operating Income Q1 2014 · Mar 31, 2013 $10.07M
Revenue Q1 2014 · Mar 31, 2014 $6.42M
Revenue Q1 2014 · Mar 31, 2013 $39.33M
Capex Q1 2014 · Mar 31, 2013 $2K